Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Richard Duke to Mice

This is a "connection" page, showing publications Richard Duke has written about Mice.

 
Connection Strength
 
 
 
0.159
 
  1. Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine. 2007 Feb 09; 25(8):1452-63.
    View in: PubMed
    Score: 0.022
  2. Duke RC, Newell E, Schleicher M, Meech S, Bellgrau D. Transplantation of cells and tissues expressing Fas ligand. Transplant Proc. 1999 May; 31(3):1479-81.
    View in: PubMed
    Score: 0.013
  3. Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells. Cell Death Differ. 1999 Feb; 6(2):175-82.
    View in: PubMed
    Score: 0.013
  4. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature. 1995 Oct 19; 377(6550):630-2.
    View in: PubMed
    Score: 0.010
  5. Duke RC, Witter RZ, Nash PB, Young JD, Ojcius DM. Cytolysis mediated by ionophores and pore-forming agents: role of intracellular calcium in apoptosis. FASEB J. 1994 Feb; 8(2):237-46.
    View in: PubMed
    Score: 0.009
  6. Bui MR, Hodson V, King T, Leopold D, Dai S, Fiolkoski V, Oakes S, Duke R, Apelian D, Franzusoff A, DeGregori J. Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model. Vaccine. 2010 Aug 23; 28(37):6028-35.
    View in: PubMed
    Score: 0.007
  7. Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD. Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med. 1989 Oct 01; 170(4):1451-6.
    View in: PubMed
    Score: 0.007
  8. Duke RC. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med. 1989 Jul 01; 170(1):59-71.
    View in: PubMed
    Score: 0.007
  9. Duke RC, Sellins KS, Cohen JJ. Cytotoxic lymphocyte-derived lytic granules do not induce DNA fragmentation in target cells. J Immunol. 1988 Oct 01; 141(7):2191-4.
    View in: PubMed
    Score: 0.006
  10. Duke RC, Cohen JJ, Chervenak R. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. J Immunol. 1986 Sep 01; 137(5):1442-7.
    View in: PubMed
    Score: 0.006
  11. Duke RC, Cohen JJ. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 1986; 5(4):289-99.
    View in: PubMed
    Score: 0.005
  12. Lu Y, Bellgrau D, Dwyer-Nield LD, Malkinson AM, Duke RC, Rodell TC, Franzusoff A. Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res. 2004 Aug 01; 64(15):5084-8.
    View in: PubMed
    Score: 0.005
  13. Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clin Immunol. 2004 Jul; 112(1):54-65.
    View in: PubMed
    Score: 0.005
  14. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 1984 Jan; 132(1):38-42.
    View in: PubMed
    Score: 0.005
  15. Duke RC, Chervenak R, Cohen JJ. Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci U S A. 1983 Oct; 80(20):6361-5.
    View in: PubMed
    Score: 0.005
  16. Zuraff-Perryman LA, Duke RC, Setser E, Nelson DP, Bellgrau D. Murine heart transgenic Fas ligand expression protects against allograft rejection. Transplant Proc. 2002 Dec; 34(8):3396-8.
    View in: PubMed
    Score: 0.004
  17. Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med. 2001 May; 7(5):625-9.
    View in: PubMed
    Score: 0.004
  18. Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, Osinska H, Bellgrau D, Duke RC, Robbins J. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest. 2000 May; 105(9):1199-208.
    View in: PubMed
    Score: 0.004
  19. Desbarats J, Duke RC, Newell MK. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat Med. 1998 Dec; 4(12):1377-82.
    View in: PubMed
    Score: 0.003
  20. Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13159-64.
    View in: PubMed
    Score: 0.003
  21. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol. 1998 Feb 15; 160(4):1824-30.
    View in: PubMed
    Score: 0.003
  22. Berggren RE, Wunderlich A, Ziegler E, Schleicher M, Duke RC, Looney D, Fang FC. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15; 10(5):489-95.
    View in: PubMed
    Score: 0.003
  23. Walsh P, Dorner A, Duke RC, Su LJ, Glode LM. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma. J Natl Cancer Inst. 1995 Jun 07; 87(11):809-16.
    View in: PubMed
    Score: 0.003
  24. Kozono Y, Duke RC, Schleicher MS, Holers VM. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur J Immunol. 1995 Apr; 25(4):1013-7.
    View in: PubMed
    Score: 0.003
  25. Cohen CJ, Duke RC, Sellins KS. Stimulation by superantigen. Nature. 1991 Jul 18; 352(6332):199-200.
    View in: PubMed
    Score: 0.002
  26. Pettijohn DE, Pfenninger O, Brown J, Duke R, Olsson L. Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells. Proc Natl Acad Sci U S A. 1988 Feb; 85(3):802-6.
    View in: PubMed
    Score: 0.002
  27. Cohen JJ, Duke RC, Chervenak R, Sellins KS, Olson LK. DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. Adv Exp Med Biol. 1985; 184:493-508.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)